Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK1 | P23458 | 18/20 | 0.42 |
| ▸ | JAK2 | O60674 | 16/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19953558 | 0.85 | USP2 (0.52) | JAK1JAK2USP2SMN1; SMN2 | |
| SCHEMBL29187312 | 0.82 | JAK1 (0.45) | JAK1JAK2 | |
| SCHEMBL16989670 | 0.80 | JAK1 (0.48) | JAK1JAK2 | |
| SCHEMBL2077067 | 0.77 | USP2 (0.59) | USP2SMN1; SMN2 | |
| SCHEMBL21784364 | 0.76 | KDM1A (0.39) | JAK1JAK2 | |
| SCHEMBL31479119 | 0.74 | USP2 (0.47) | JAK1JAK2USP2SMN1; SMN2 | |
| SCHEMBL10062603 | 0.74 | USP2 (0.49) | USP2SMN1; SMN2 | |
| SCHEMBL18655778 | 0.73 | USP2 (0.46) | USP2SMN1; SMN2 | |
| SCHEMBL9921830 | 0.71 | MEN1 (0.44) | JAK1JAK2USP2SMN1; SMN2 | |
| SCHEMBL20347009 | 0.71 | USP2 (0.56) | USP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11512064-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2022-11-29 | — | — | US | disclosed |
| US-20210300891-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION | 2021-09-30 | — | — | US | disclosed |
| US-10968200-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2021-04-06 | — | — | US | disclosed |
| WO-2020047198-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION (US) | 2020-03-05 | — | — | WO | disclosed |
| US-20200071289-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | WILMINGTON PHARMATECH | 2020-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11512064-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | KDM1A, KDM1B, KDM2A | JAK1 864/4885JAK2 441/4885USP2 357/4885 |
| US-20200071289-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | KDM1A, KDM1B, KDM2A | JAK1 864/4885JAK2 441/4885USP2 357/4885 |
| US-20210300891-A1 | SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME | KDM1A, KDM1B, KDM2A | JAK1 864/4885JAK2 441/4885USP2 357/4885 |
| US-10968200-B2 | Salts of an LSD1 inhibitor and processes for preparing the same | KDM1A, KDM1B, KDM2A | JAK1 864/4885JAK2 441/4885USP2 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.